Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexicon Pharmaceuticals

0.6958
-0.0063-0.90%
Post-market: 0.71300.0172+2.47%19:55 EDT
Volume:2.29M
Turnover:1.60M
Market Cap:252.70M
PE:-1.37
High:0.7190
Open:0.7020
Low:0.6803
Close:0.7021
Loading ...

Lexicon appoints Scott Coiante as CFO

TIPRANKS
·
02 Jan

Lexicon Appoints Scott Coiante as Chief Financial Officer

THOMSON REUTERS
·
02 Jan

Press Release: Lexicon Appoints Scott Coiante as Chief Financial Officer

Dow Jones
·
02 Jan

Private equity firms account for 47% of Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) ownership, while institutions account for 33%

Simply Wall St.
·
30 Dec 2024

Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX), Arcutis Biotherapeutics (ARQT) and Viking Therapeutics (VKTX)

TIPRANKS
·
25 Dec 2024

Lexicon Pharmaceuticals Shares Fall 9% After FDA Declines to Approve Its Add-on Diabetes Drug

THOMSON REUTERS
·
23 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
23 Dec 2024

Lexicon Pharma Falls 11.9% Premarket After FDA Declines to Approve Its Add-on Diabetes Drug

THOMSON REUTERS
·
23 Dec 2024

BUZZ-Lexicon Pharma falls after FDA declines to approve its add-on diabetes drug

Reuters
·
23 Dec 2024

Needham Remains a Hold on Lexicon Pharmaceuticals (LXRX)

TIPRANKS
·
23 Dec 2024

Stocks to Watch: Rumble, Lexicon Pharmaceuticals

Dow Jones
·
21 Dec 2024

Lexicon Receives Complete Response Letter from FDA for Diabetes, Kidney Disease Treatment

Dow Jones
·
21 Dec 2024

BRIEF-Lexicon Announces Receipt Of Complete Response Letter For Zynquista (Sotagliflozin)

Reuters
·
21 Dec 2024

Lexicon Fails to Secure FDA Approval for Zynquista -- Shares Fall After Hours

MT Newswires Live
·
21 Dec 2024

US FDA declines to approve Lexicon Pharma's add-on diabetes drug

Reuters
·
21 Dec 2024

Lexicon receives CRL for Zynquista

TIPRANKS
·
21 Dec 2024

Lexicon Pharmaceuticals Inc - to Discontinue Zynquista Launch Preparations

THOMSON REUTERS
·
21 Dec 2024

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (Sotagliflozin)

THOMSON REUTERS
·
21 Dec 2024